8-K
filed April 27, 2023, 7:59 PM ET
ticker CI
CIK 0001739940
other material
confidence high
sentiment neutral
materiality 0.15
Cigna shareholders elect all 11 directors, approve say-on-pay and charter amendment at 2023 annual meeting
Cigna Group
- All 11 director nominees elected; David M. Cordani received 235M votes for, 15.5M against.
- Say-on-pay approved with 221.4M votes for (29.7M against).
- Annual frequency for say-on-pay votes adopted with 247.5M votes for one year.
- Charter amendment limiting officer liability approved with 222.9M votes for (28.4M against).
- Shareholder proposal on special meetings failed: 117.4M for, 133.6M against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders approved Advisory approval of The Cigna Group's executive compensation at the 2023-04-26 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 2: Advisory approval of The Cigna Group’s executive compensation. Votes For Votes Against Abstentions Broker Non-Votes 221,436,565 29,691,242 611,774 18,315,429
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders rejected Shareholder Proposal – Special shareholder meeting improvement at the 2023-04-26 meeting.
- Outcome
- failed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 6: Shareholder Proposal – Special shareholder meeting improvement. Votes For Votes Against Abstentions Broker Non-Votes 117,434,728 133,649,193 655,660 18,315,429
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders approved Election of eleven director nominees named in the 2023 Proxy Statement for one-year terms at the 2023-04-26 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 1: Shareholders elected the eleven director nominees named in the 2023 Proxy Statement for one-year terms to expire at the next annual meeting of shareholders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders approved Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law at the 2023-04-26 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 5: Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent amendments to the Delaware General Corporation Law. Votes For Votes Against Abstentions Broker Non-Votes 222,860,732 28,396,757 482,092 18,315,429
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023 at the 2023-04-26 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 4: Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2023. Votes For Votes Against Abstentions 252,867,500 16,905,824 281,686
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cigna Group shareholders approved Advisory approval of the frequency of future advisory votes on executive compensation at the 2023-04-26 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-04-26
Exact text from the filing
Proposal 3: Advisory approval of the frequency of future advisory votes on executive compensation. One Year Two Years Three Years Abstentions 247,538,876 179,056 3,654,770 366,879
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.